In acute ischemic stroke and high-risk transient ischemic attack patients, does the addition of clopidogrel to daily aspirin reduce the risk of major ischemic vascular events at 90 days?

BEEM Bottom Line

Why is this study important?

Following an ischemic stroke or transient ischemic attack (TIA), there is increased risk of a subsequent stroke. This risk can be mitigated with antiplatelet therapy, but at the increased risk of bleeding. This is the largest trial to date assessing the effectiveness and safety of combined clopidogrel and aspirin (ASA) in minor ischemic stroke or high-risk TIA patients.

Which, if any, threats to validity are most likely to have an impact on the results and how?

Thank you for your interest in the BEEM Journal!

To read the rest of this article or to access the entire collection of BEEM Critical Appraisals, please purchase a subscription at the link below.

If you would like a pre-view, click here to view some sample articles

Premium Content Available Through Subscription

BEEM is a knowledge translation project which aims to extract the most recent, EM relevant, and valid evidence from the volumes of available medical research and deliver it to EM practitioners in an easily consumable format to help guide their clinical practice. This valuable distilled information provided by BEEM is available through BEEM's accredited CME courses or through our online journal.

A BEEM Journal Subscription will provide you with unlimited access to our entire collection of Critical Appraisals for 1 year.